공지 : 도쿄증권거래소 JASDAQ 스탠다드 시장 신규 상장 관련 안내

Global Information
회사소개 | 문의 | 비교리스트

세계의 전신 마취제 시장 : 분자 유형, 지역별 - 규모, 점유율, 전망, 기회 분석(2019-2027년)

General Anesthesia Drugs Market, By Molecule Type and By Region - Size, Share, Outlook, and Opportunity Analysis, 2019 - 2027

리서치사 Coherent Market Insights
발행일 2019년 12월 상품 코드 920730
페이지 정보 영문
가격
US $ 4,500 ₩ 4,997,000 PPT Turned PDF (Single User License)
US $ 7,000 ₩ 7,774,000 PPT Turned PDF (Multi-user License)
US $ 10,000 ₩ 11,106,000 PPT Turned PDF (Enterprise User License)


세계의 전신 마취제 시장 : 분자 유형, 지역별 - 규모, 점유율, 전망, 기회 분석(2019-2027년) General Anesthesia Drugs Market, By Molecule Type and By Region - Size, Share, Outlook, and Opportunity Analysis, 2019 - 2027
발행일 : 2019년 12월 페이지 정보 : 영문

본 상품은 영문 자료로 한글과 영문목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문목차를 참고해주시기 바랍니다.

세계의 전신 마취제(General Anesthesia Drugs) 시장에 대해 조사했으며, 시장 기회, 제품 발매, 영향 분석, 성장 및 저해요인, 분자 유형·지역별 시장 분석, 경쟁 구도, 주요 기업의 개요 등의 정보를 정리하여 전해드립니다.

목차

제1장 조사 목적·전제조건

  • 조사 목적
  • 전제조건
  • 약어

제2장 시장 범위

  • 리포트 설명
    • 시장의 정의와 범위
  • 개요
    • 분자 유형별
    • 지역별
    • Coherent Opportunity Map(COM)

제3장 시장 역학, 규제, 동향 분석

  • 시장 역학
    • 성장요인
    • 저해요인
    • 시장 기회
  • 영향 분석
  • 주요 하이라이트
  • 제품 발매
  • 규제 시나리오
  • PEST 분석
  • 합병과 인수

제4장 시장 분석 : 분자 유형별

  • 서론
  • Propofol
  • Sevoflurane
  • Dexmedetomidine
  • Desflurane
  • Remifentanil
  • Midazolam
  • 기타

제5장 시장 분석 : 지역별

  • 서론
  • 북미
  • 라틴아메리카
  • 유럽
  • 아시아태평양
  • 중동
  • 아프리카

제6장 경쟁 구도

  • 기업 개요
    • Baxter International Inc.
    • AstraZeneca
    • AbbVie Inc.
    • B. Braun Melsungen AG
    • Fresenius SE & Co. KGaA
    • Hospira Inc.

제7장 섹션

  • 참조 자료
  • 조사 방법
  • Coherent Market Insights 소개
KSA 20.01.31

Title:
General Anesthesia Drugs Market, By Molecule Type (Propofol, Sevoflurane, Dexmedetomidine, Desflurane, Remifentanil, Midazolam, Others) and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2019 - 2027.

General anesthesia is a therapeutically induced condition of unconsciousness; that is, loss of protective reflexes, which results from the use of one or multiple general anesthetic agents. The drug is administered to allow performing the medical procedures which are unbearably painful for the patient. A range of medicines can be administered, the overall aim of which is to ensure unconsciousness, analgesia, and loss of reflexes of the ANS or autonomic nervous system. In some cases, general anesthetic drugs are used for paralyzing the skeletal muscles.

Key features of the study::

  • This report provides in-depth analysis of the General Anesthesia Drugs market and provides market size (US$ million) and compound annual growth rate (CAGR %) for the forecast period (2019-2027), considering 2018 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategy adopted by key players
  • It profiles key players in the global General Anesthesia Drugs market based on the following parameters - company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
  • Key companies covered as a part of this study include, Baxter International Inc., AstraZeneca, AbbVie Inc., B. Braun Melsungen AG, Fresenius SE & Co. KGaA, and Hospira Inc.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, technology up-gradation, market expansion, and marketing tactics
  • The global General Anesthesia Drugs market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global General Anesthesia Drugs market

Detailed Segmentation::

  • General Anesthesia Drugs Market, By Molecule Type:
    • Propofol
    • Sevoflurane
    • Dexmedetomidine
    • Desflurane
    • Remifentanil
    • Midazolam
    • Others
  • General Anesthesia Drugs Market, By Region:
    • North America
      • By Molecule Type:
      • Propofol
      • Sevoflurane
      • Dexmedetomidine
      • Desflurane
      • Remifentanil
      • Midazolam
      • Others
      • By Country:
      • U.S.
      • Canada
    • Latin America
      • By Molecule Type:
      • Propofol
      • Sevoflurane
      • Dexmedetomidine
      • Desflurane
      • Remifentanil
      • Midazolam
      • Others
      • By Country:
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
    • Europe
      • By Molecule Type:
      • Propofol
      • Sevoflurane
      • Dexmedetomidine
      • Desflurane
      • Remifentanil
      • Midazolam
      • Others
      • By Country:
      • Germany
      • U.K.
      • France
      • Italy
      • Spain
      • Russia
      • Rest of Europe
    • Asia Pacific
      • By Molecule Type:
      • Propofol
      • Sevoflurane
      • Dexmedetomidine
      • Desflurane
      • Remifentanil
      • Midazolam
      • Others
      • By Country:
      • China
      • India
      • Japan
      • Australia
      • South Korea
      • ASEAN
      • Rest of Asia Pacific
    • Middle East
      • By Molecule Type:
      • Propofol
      • Sevoflurane
      • Dexmedetomidine
      • Desflurane
      • Remifentanil
      • Midazolam
      • Others
      • By Country:
      • GCC
      • Israel
      • Rest of Middle East
    • Africa
      • By Molecule Type:
      • Propofol
      • Sevoflurane
      • Dexmedetomidine
      • Desflurane
      • Remifentanil
      • Midazolam
      • Others
      • By Country:
      • South Africa
      • Central Africa
      • North Africa
  • Company Profiles
    • Baxter International Inc. *
      • Company Overview
      • Product Portfolio
      • Key Highlights
      • Financial Overview
      • Strategies
    • AstraZeneca
    • AbbVie Inc.
    • B. Braun Melsungen AG
    • Fresenius SE & Co. KGaA
    • Hospira Inc.

"*" marked represents similar segmentation in other categories in the respective section.

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snippet, By Molecule Type
    • Market Snippet, By Region
    • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Market Opportunities
  • Impact Analysis
  • Key Highlights
  • Product launch
  • Regulatory Scenario
  • PEST Analysis
  • Mergers and Acquisitions

4. Global General Anesthesia Drugs Market, By Molecule Type, 2019 - 2027, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2019 and 2027 (%)
    • Y-o-Y Growth Analysis, 2017 - 2027
    • Segment Trends
  • Propofol
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Million)
    • Keratolytics
    • Moisturizers
    • Retinoids
    • SunScreens
    • Hair Removals
  • Sevoflurane
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Million)
  • Dexmedetomidine
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Million)
  • Desflurane
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Million)
  • Remifentanil
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Million)
  • Midazolam
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Million)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Million)

5. Global General Anesthesia Drugs Market, By Region, 2019 - 2027, (US$ Mn)

  • Introduction
    • Market Share Analysis, By Region, 2019 and 2027 (%)
    • Y-o-Y Growth Analysis, For Regions, 2017-2026
  • North America
    • Market Size and Forecast, By Molecule Type, 2016 - 2027, (US$ Million)
    • Market Size and Forecast, By Country, 2016 - 2027, (US$ Million)
    • U.S.
    • Canada
  • Latin America
    • Market Size and Forecast, By Molecule Type, 2016 - 2027, (US$ Million)
    • Market Size and Forecast, By Country, 2016 - 2027, (US$ Million)
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
  • Europe
    • Market Size and Forecast, By Molecule Type, 2016 - 2027, (US$ Million)
    • Market Size and Forecast, By Country, 2016 - 2027, (US$ Million)
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Russia
    • Rest of Europe
  • Asia Pacific
    • Market Size and Forecast, By Molecule Type, 2016 - 2027, (US$ Million)
    • Market Size and Forecast, By Country, 2016 - 2027, (US$ Million)
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of APAC
  • Middle East
    • Market Size and Forecast, By Molecule Type, 2016 - 2027, (US$ Million)
    • Market Size and Forecast, By Country, 2016 - 2027, (US$ Million)
    • GCC
    • Israel
    • Rest of Middle East
  • Africa
    • Market Size and Forecast, By Molecule Type, 2016 - 2027, (US$ Million)
    • Market Size and Forecast, By Country, 2016 - 2027, (US$ Million)
    • South Africa
    • Central Africa
    • North Africa

6. Competitive Landscape

  • Company Profiles
    • Baxter International Inc.
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • AstraZeneca
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • AbbVie Inc.
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • B. Braun Melsungen AG
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Fresenius SE & Co. KGaA
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Hospira Inc.
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies

7. Section

  • References
  • Research Methodology
  • About us and Sales Contact
Back to Top
전화 문의
F A Q